An off-stage interview with Silvia Cerolini, Founder and CEO at Eyes on the Future.

In her keynote, Silvia shared how patients are not just informing drug development but co-creating it—reshaping the rare disease landscape and offering a blueprint for the future of patient-driven, personalized medicine. Her story is both a call to action and an invitation: to rethink how treatments are developed and to join a movement that puts patients at the center of innovation.